Hill notes up to 40% of weight lost on these drugs isn't fat, but argues lean mass on a scan and actual muscle are not the same thing.
Recap by typeshit. Post by @simonhill on Instagram.
A Future Health & Medical Innovation panel weighs how much of the growing interest in peptides and exosomes is backed by evidence.
The aging doctor shares a headline saying new studies point to GLP-1 drugs slowing the biological clock, and notes himself that more research is needed.
An explainer on how GLP-1 drugs act on reward and craving in the brain, and the research testing them against alcohol, nicotine and other substance use.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
56:52
The hosts trade their own experiences with retatrutide, the weight loss drug still in trials, and debate whether it's worth it. Personal accounts, not medical advice.
The update backs the drugs alongside lifestyle programs instead of after they fail, and advises against stopping them once they work, a shift for millions of veterans.
Loading…